Zhenhao Shi
Research Assistant Professor of Psychiatry
Department: Psychiatry
Contact information
3535 Market St Ste 500
Philadelphia, PA 19104
Philadelphia, PA 19104
Office: 2157461822
Publications
Education:
BS (Psychology)
Peking University, 2009.
PhD (Cognitive Neuroscience)
Peking University, 2014.
BS (Psychology)
Peking University, 2009.
PhD (Cognitive Neuroscience)
Peking University, 2014.
Post-Graduate Training
Postdoctoral Fellow in Health Communication, Annenberg Public Policy Center, University of Pennsylvania, 2014-2016.
Postdoctoral Fellow in Addiction, Center for Studies of Addiction, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, 2016-2021.
Permanent linkPostdoctoral Fellow in Health Communication, Annenberg Public Policy Center, University of Pennsylvania, 2014-2016.
Postdoctoral Fellow in Addiction, Center for Studies of Addiction, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, 2016-2021.
Description of Research Expertise
Brain imaging, Public health, Social neuroscience, Translational neuroscience, Computational psychiatry, Substance use disorder, Tobacco control, Health communication, Cross-cultural psychologySelected Publications
Shi Z, Li X, Todaro DR, Cao W, Lynch KG, Detre JA, Loughead J, Langleben DD, Wiers CE.: Medial prefrontal neuroplasticity during extended-release naltrexone treatment of opioid use disorder - a longitudinal structural magnetic resonance imaging study. Transl Psychiatry 14: 360, Sep 2024.Li X, Ramos-Rolón AP, Kass G, Pereira-Rufino LS, Shifman N, Shi Z, Volkow ND, Wiers CE.: Imaging neuroinflammation in individuals with substance use disorders. J Clin Invest 134: e172884, Jun 2024.
Todaro DR, Volkow ND, Langleben DD, Shi Z, Wiers CE.: Collateral Damage: Neurological Correlates of Non-Fatal Overdose in the Era of Fentanyl-Xylazine. Neurosci Insights 19: 26331055241247156, Apr 2024.
Shi Z, D Langleben D, Rott D, Albanese M, Elman I.: Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity. J Addict Dis Mar 2024.
Li X, Shi Z, Todaro DR, Pond T, Byanyima JI, Vesslee SA, Reddy R, Nanga RPR, Kass G, Ramchandani V, Kranzler HR, Vendruscolo JCM, Vendruscolo LF, Wiers CE.: Ketone Supplementation Dampens Subjective and Objective Responses to Alcohol: Evidence From a Preclinical Rat Study and a Randomized, Cross-Over Trial in Healthy Volunteers. Int J Neuropsychopharmacol 27: pyae009, Feb 2024.
Shi Z, Wang AL, Audrain-McGovern J, Lynch KG, Loughead J, Langleben DD.: Delayed effects of cigarette graphic warning labels on smoking behavior. medRxiv Jan 2024.
Liu J, Shi Z, Fabbricatore JL, McMains JT, Worsdale A, Jones EC, Wang Y, Sweet LH.: Vaping and smoking cue reactivity in young adult electronic cigarette users who have never smoked combustible cigarettes: A functional neuroimaging study. bioRxiv Jan 2024.
Li X, Kass G, Wiers CE, Shi Z.: The Brain Salience Network at the Intersection of Pain and Substance use Disorders: Insights from Functional Neuroimaging Research. Curr Addict Rep 2024.
Shi Z, Liu J: Vaping and smoking cue-reactivity in young adult electronic cigarette vapers who never smoke combustible cigarettes – a functional neuroimaging study. Poster presentation at the 14th Annual Meeting of the Society for Social Neuroscience, virtual meeting. Page: 0-0, Nov 2023.
Li X, Young AJ, Pereira-Rufino LS, Shi Z, Byanyima J, Vesslee S, Reddy R, Pond T, Elliott M, Reddy R, Doot RK, van der Veen JW, Kranzler HR, Reddy Nanga RP, Dubroff JG, Wiers CE.: Pharmacokinetic effects of a single-dose nutritional ketone ester supplement on brain ketone and glucose metabolism in alcohol use disorder - a pilot study. medRxiv Sep 2023.